IRIS
CIPRIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.378
AS - Asia 6.015
EU - Europa 5.561
SA - Sud America 685
AF - Africa 82
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 17
Totale 22.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.245
SG - Singapore 2.820
IE - Irlanda 1.626
CN - Cina 1.356
TR - Turchia 713
HK - Hong Kong 694
RU - Federazione Russa 679
IT - Italia 651
SE - Svezia 611
BR - Brasile 602
DE - Germania 570
UA - Ucraina 405
GB - Regno Unito 367
FI - Finlandia 219
FR - Francia 178
VN - Vietnam 127
IN - India 99
CA - Canada 81
JP - Giappone 47
BE - Belgio 46
NL - Olanda 41
ZA - Sudafrica 37
AR - Argentina 32
MX - Messico 32
BD - Bangladesh 29
ES - Italia 29
LT - Lituania 27
PL - Polonia 25
CZ - Repubblica Ceca 22
ID - Indonesia 18
AU - Australia 15
EC - Ecuador 14
EU - Europa 14
AT - Austria 12
IQ - Iraq 12
PK - Pakistan 12
MA - Marocco 11
VE - Venezuela 11
SA - Arabia Saudita 10
CO - Colombia 9
JO - Giordania 9
UZ - Uzbekistan 9
GR - Grecia 8
JM - Giamaica 7
NZ - Nuova Zelanda 7
AZ - Azerbaigian 6
CH - Svizzera 6
DZ - Algeria 6
KR - Corea 6
MK - Macedonia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EG - Egitto 5
IL - Israele 5
LB - Libano 5
NP - Nepal 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
LU - Lussemburgo 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
ET - Etiopia 1
GM - Gambi 1
HR - Croazia 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
Totale 22.748
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.642
Dublin 1.620
Chandler 1.609
Singapore 1.416
Dallas 1.180
Hong Kong 692
Santa Clara 617
Boardman 579
Ashburn 439
Izmir 403
New York 303
Nanjing 273
Wilmington 246
Lawrence 235
Princeton 235
San Mateo 225
Beijing 206
Ann Arbor 196
Moscow 159
Los Angeles 134
L'aquila 129
Nanchang 100
Milan 97
Hefei 89
The Dalles 86
Dearborn 85
Woodbridge 82
Munich 81
Seattle 76
Shenyang 65
São Paulo 59
Helsinki 55
Des Moines 52
Verona 50
Kunming 46
Council Bluffs 45
Shanghai 45
Tokyo 45
Columbus 43
Mountain View 43
Brussels 42
Hebei 42
L’Aquila 42
Jiaxing 41
Ho Chi Minh City 40
Jinan 35
Dong Ket 34
Rome 33
Tianjin 33
Changsha 31
Zhengzhou 29
Frankfurt am Main 27
Norwalk 27
Phoenix 27
Stockholm 27
Johannesburg 26
Pune 25
Brooklyn 24
Houston 24
Philadelphia 23
Montreal 21
Warsaw 21
Pescara 20
Chicago 19
Guangzhou 19
Hangzhou 19
London 19
Rio de Janeiro 19
San Francisco 19
Brno 18
Ningbo 18
Falkenstein 17
Hanoi 17
Ankara 16
Assago 16
Atlanta 16
Chennai 16
Manchester 16
Orem 16
Boston 15
Kitzingen 15
Brasília 14
Denver 14
New Delhi 14
Toronto 14
Amsterdam 13
Belo Horizonte 13
Mexico City 13
Lappeenranta 12
Charlotte 11
Guarulhos 11
Jakarta 11
Lanzhou 11
Bremen 10
Cedar Knolls 10
Poplar 10
Redwood City 10
Washington 10
Amman 9
Changchun 9
Totale 15.005
Salva come PNG Salva come JPEG
Nome #
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 171
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 154
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 146
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 142
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 138
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 137
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 135
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 131
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 130
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 130
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 130
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 129
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 128
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 128
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 126
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 125
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 124
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 122
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 122
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 121
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 119
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 115
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 113
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 113
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 112
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 111
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 111
Cardiovascular disease in primary sjögren’s syndrome 111
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 110
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 109
Stem cell therapies for systemic sclerosis 108
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 108
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 107
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 107
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 107
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 107
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 106
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 106
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 106
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 105
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 104
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 104
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 103
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 103
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 103
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 102
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 102
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 101
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 101
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 101
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 101
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 100
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 100
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 99
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 99
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 99
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 98
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 97
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 97
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 97
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 97
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 96
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 96
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 96
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 96
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 95
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 94
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 94
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 94
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 94
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 94
DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 93
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 93
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 93
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 93
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 93
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 92
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 92
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 92
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 92
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 91
Computed Tomography and MR Imaging in Rheumatoid Arthritis 91
Interstitial lung disease in systemic sclerosis: current and future treatment. 91
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 90
Myositis in primary Sjögren's syndrome: data from a multicentre cohort. 90
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.. Epub 2002 Aug 30 90
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 90
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 90
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study 90
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 89
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 89
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 89
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 89
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 89
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 89
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 89
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease 88
Combined approach to the initial stage raynaud's phenomenon diagnosis by means of dynamic digital telethermography, capillaroscopy and pletismography preliminary findings. 88
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 88
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 88
Totale 10.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.144 0 0 0 0 0 86 254 20 236 73 371 104
2021/20221.310 74 88 249 96 33 19 28 63 108 68 93 391
2022/20234.607 336 251 82 479 395 489 31 298 2.013 30 143 60
2023/20241.248 168 74 82 157 106 363 25 73 9 57 36 98
2024/20255.119 114 89 484 180 650 461 673 394 1.179 213 346 336
2025/20264.495 535 1.005 748 1.149 942 116 0 0 0 0 0 0
Totale 23.102